Ka. Athanasiou et al., IN-VITRO DEGRADATION AND RELEASE CHARACTERISTICS OF BIODEGRADABLE IMPLANTS CONTAINING TRYPSIN-INHIBITOR, Clinical orthopaedics and related research, (315), 1995, pp. 272-281
The use of a biodegradable implant system that provides a steady, cont
rolled release of drugs or bioactive factors can be an attractive deli
very vehicle of substances that can enhance repair processes in the mu
sculoskeletal system. The present in vitro study examined the degradat
ive characteristics and release kinetics of a 50 to 50 polylactic acid
/polyglycolic acid implant, used as a carrier of trypsin inhibitor, du
ring a 10-week period. Morphological and scanning electron microscopic
examinations demonstrated that the implant degraded in a gradual, ext
ended fashion such that by 10 weeks the implant was completely dissolv
ed. It also was shown that the protein was released from the implant i
n a sigmoidal fashion with increased release between 3 and 7 weeks. Mo
re than 95% of the trypsin inhibitor originally incorporated in the im
plants was released during the 10-week test period. To describe furthe
r the degradation process of the implant, temporal changes in its mole
cular weight and surface axial strain were determined also. It was sho
wn that in the initial 4 weeks, there was a marked decrease in molecul
ar weight of the implants. Axial strain decreased and then increased o
ver time, suggesting an initial period of stiffening followed by a per
iod of degradative softening.